Piramal launches integrated platform for CDMO services

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/NicoElNino)
(Image: Getty/NicoElNino)

Related tags: CDMO, Manufacturing, Drug development

The contract development and manufacturing organization (CDMO) Piramal Pharma Solutions has launched its Xcelerate Integrated Solutions platform.

Over the last two years, Piramal Pharma Solutions (PPS) has integrated its drug discovery and commercialization services, while addressing gaps through acquisitions and internal investment, according to the company.

The CDMO’s platform provides integrated solutions for orphan diseases, niche therapies, and fast track medicines.

Mr. Vivek Sharma, CEO, Piramal Pharma Solutions said in a press release, "This platform is a result of the growing interest from our customers on structuring preferred relationships with global leaders such as Piramal who can offer end-to-end solutions, coupled with our desire to collaborate with strategic partners."

PPS has 12 research and development and manufacturing locations across North America, Europe, and Asia.

Its consolidated revenues were more than $1.6bn in FY2018, with around 46% of revenues generated from outside India.

PPS has not responded to a request for comment.

Related news

Show more

Related products

show more

Validating The Simoa Technology

Validating The Simoa Technology

Frontage Laboratories | 01-Oct-2019 | Technical / White Paper

Frontage is the first and only laboratory to validate Quanterix’ Simoa HD1 Analyzer for performing immunoassays. Most of the advanced instruments used...

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Related suppliers

Follow us

Products

View more

Webinars